AKT1 and glioblastoma: Because STAT3 deletion activates Akt at S473, which inhibits TCS2 via phosphorylation at T1462, resulting in basal mTORC1 activation, we speculate that baseline activation of mTORC1 in GBM cells could phosphorylate and inhibit ULK1 at S638.